Biorasi Delivers.
20+ Years of CRO Results
Sponsors rely on Biorasi for complex clinical trials that demand reliability, flexibility, and transparency. From small biotech to mid-sized biopharma, we bring innovative, lifesaving therapies to market.
5 FDA Approvals
We’ve reached five approved clinical trials and counting.
OUR APPROACH IS BUILT ON THE ESSENTIALS EVERY SPONSOR DESERVES.
Real-Time
KPI Metrics
Critical trial data reporting across 15 visual dashboards.
- Address challenges before they happen.
- Track key milestones in real-time.
Dedicated
Teams
Proven experts to guide clinical trials from start to finish.
- Work hand-in-hand across all key departments.
- Access to Biorasi leaders and clinical advisors.
Personalized
Study Solutions
Custom strategies that match short and long-term goals.
- Engage AI-powered and outreach focused clinical site feasibility.
- Select from comprehensive solutions to standalone services.
FROM OUR PARTNERS
Hyun Kim
VP Clinical Operations, AOBiome Therapeutics
I cannot think of anyone else to work with other than Biorasi
Our relationship is not just a Sponsor-CRO relationship. It is really a true partnership.
Supriya Lala Kundu
Research Analyst, Best Practices, Frost & Sullivan
Biorasi provides the necessary framework, capability, scalability, and flexibility for protocol design and enhancement as per the evolving regulatory environment, early in the clinical trial process, to seamlessly progress the trial. An expert in digital therapeutic trials, the company flexibly manages the trial complexity, clinical validation, regulatory approval, and payer reimbursement.
Amy Beasley
Former Manager of Clinical Operations, Savara Pharmaceuticals
Biorasi far exceeds other vendors.
“For flexibility, nimbleness, and willingness to partner with us to solve our problems, Biorasi far exceeds other vendors. They give attention and detail to smaller-sized companies like us, and provide a great strategic value.”
Mary Varhgese Presti
Vice President, Life Sciences, IBM Watson Health
Biorasi and IBM Health: Greater Efficiency and Precision
Biorasi has been at the forefront of e-clinical innovation and has demonstrated continued leadership in leveraging the ICD platform. We are proud to support Biorasi’s ongoing effort to bring greater efficiency and precision to the clinical trial process, particularly in emerging areas such as digital therapeutics, virtual trials, and precision medicine.